Literature DB >> 35841108

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Courtney T van Geelen1, Peter Savas1,2, Zhi Ling Teo1, Stephen J Luen1,2, Chen-Fang Weng1, Yi-An Ko1, Keilly S Kuykhoven3, Franco Caramia1, Roberto Salgado1, Prudence A Francis2,4, Sarah-Jane Dawson1,2,4, Stephen B Fox1,5,4, Andrew Fellowes5, Sherene Loi6,7,8.   

Abstract

Entities:  

Year:  2022        PMID： 35841108      PMCID： PMC9284837          DOI： 10.1186/s13058-022-01539-7

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN： 1465-5411            Impact factor:   8.408


× No keyword cloud information.

Correction to: Breast Cancer Research (2020) 22:91 10.1186/s13058-020-01328-0

Following publication of the original article [1], the authors identified some errors in Fig. 4. The correct figure is given below.
Fig. 4

Prognostic associations in this cohort of sequenced metastatic breast cancer patients. a Overall survival by subtype for all recruited patients (n = 323). b Overall survival of patients based on the mutational burden of 4 mutations (75th percentile) or more (n = 234). c Overall survival of ER + HER2 − patients based on the median mutation number of 4 or more (n = 163 patients). d Table of HR for all patients and all subtypes by mutation number per sample. Patients were excluded if there was incomplete survival information. e Spread of TILs across distant metastatic site (n = 123)

Prognostic associations in this cohort of sequenced metastatic breast cancer patients. a Overall survival by subtype for all recruited patients (n = 323). b Overall survival of patients based on the mutational burden of 4 mutations (75th percentile) or more (n = 234). c Overall survival of ER + HER2 − patients based on the median mutation number of 4 or more (n = 163 patients). d Table of HR for all patients and all subtypes by mutation number per sample. Patients were excluded if there was incomplete survival information. e Spread of TILs across distant metastatic site (n = 123) The original article [1] has been corrected.
  1 in total

1.  Clinical implications of prospective genomic profiling of metastatic breast cancer patients.

Authors:  Courtney T van Geelen; Peter Savas; Zhi Ling Teo; Stephen J Luen; Chen-Fang Weng; Yi-An Ko; Keilly S Kuykhoven; Franco Caramia; Roberto Salgado; Prudence A Francis; Sarah-Jane Dawson; Stephen B Fox; Andrew Fellowes; Sherene Loi
Journal:  Breast Cancer Res       Date:  2020-08-18       Impact factor: 8.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.